Our results showed that the combination of FZKA treatment with STAT3 knock-down increased the activities of both caspase-3 and caspase-9 in lung cancer cells, compared to FZKA alone (Figures 7(b) and 7(c)). This evidence concerns the gene CASP9 and lung carcinoma.